KRAS Mutation-Related Tumors
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00112 | Bevacizumab | 1 | Recruiting | 1 |
| DB00997 | Doxorubicin | 1 | Recruiting | 1 |
| DB00544 | Fluorouracil | 1 | Recruiting | 1 |
| DB00762 | Irinotecan | 1 | Recruiting | 1 |
| DB00650 | Leucovorin | 1 | Recruiting | 1 |
| DB14786 | Nerofe | 1 | Recruiting | 1 |
| DB18397 | RGX-202 | 1 | Recruiting | 1 |
| DB16826 | Repotrectinib | 1 / 2 | Terminated | 1 |
| DB08911 | Trametinib | 1 / 2 | Terminated | 1 |
| DB11967 | Binimetinib | 2 | Active Not Recruiting | 1 |
| DB01611 | Hydroxychloroquine | 2 | Active Not Recruiting | 1 |